Clinician-Investigator Training Program, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota; Windland Smith Rice Sudden Death Genomics Laboratory, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
Heart Rhythm. 2019 Aug;16(8):1232-1239. doi: 10.1016/j.hrthm.2019.02.012. Epub 2019 Feb 11.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by adrenergically induced ventricular tachycardia, syncope, and sudden cardiac arrest (SCA). In the absence of structural disease, exercise-provoked premature ventricular contractions in bigeminy or couplets and nonsustained ventricular tachycardia are highly predictive of CPVT.
The purpose of this study was to determine the number of missed or delayed CPVT diagnoses attributable to exercise testing oversights in a cohort of young SCA survivors.
A retrospective review of 101 young SCA survivors (younger than 35 years at the time of SCA) with otherwise structurally normal hearts was used to identify those with a missed or delayed CPVT diagnosis because of overlooked evidence or lack of an exercise stress test (EST) or catecholamine provocation test (CPT) post-SCA.
Of the 101 young SCA survivors, 41 (41%) had exertion/emotion-associated SCA (EEA-SCA). After primary post-SCA investigations, a probable root cause was established in 20 of 41 EEA-SCA survivors (49%; CPVT in 8) and in 30 of 60 non-EEA-SCA survivors (50%; CPVT in 2) (P = 1). Only 14 of 21 unexplained EEA-SCA survivors (67%) had an EST/CPT performed before their referral evaluation. Secondary review of these prior ESTs/CPTs provided evidence of CPVT in 3 of 14 (21%). Of the 7 remaining unexplained cases of EAA-SCA who had never undergone an EST/CPT, 2 (29%) underwent their first EST at our institution that led to CPVT diagnosis.
Of the 15 SCA survivors diagnosed ultimately with CPVT, one-third had a delay in diagnosis because an EST was either never performed or performed but misinterpreted. EST/CPT must become the standard of care after SCA in the young, especially if the SCA occurred during either exertion or emotion.
儿茶酚胺多形性室性心动过速(CPVT)的特征是肾上腺素能诱导的室性心动过速、晕厥和心脏性猝死(SCA)。在没有结构性疾病的情况下,运动诱发的成对或二联律的过早室性收缩和非持续室性心动过速高度提示 CPVT。
本研究旨在确定在一组年轻 SCA 幸存者中,由于运动测试疏忽而导致 CPVT 漏诊或延迟诊断的数量。
对 101 例年轻 SCA 幸存者(SCA 时年龄小于 35 岁)进行回顾性分析,以确定那些因忽视证据或缺乏运动应激试验(EST)或儿茶酚胺激发试验(CPT)而导致漏诊或延迟诊断 CPVT 的患者。
在 101 例年轻 SCA 幸存者中,41 例(41%)有因运动/情绪相关的 SCA(EEA-SCA)。在 SCA 后的初步检查后,20 例 EEA-SCA 幸存者(49%;CPVT 8 例)和 30 例非 EEA-SCA 幸存者(50%;CPVT 2 例)确定了可能的根本原因(P = 1)。只有 21 例未明确原因的 EEA-SCA 幸存者中的 14 例(67%)在转诊评估前进行了 EST/CPT。对这些先前 EST/CPT 的二次回顾显示,其中 3 例(21%)有 CPVT 的证据。在未进行 EST/CPT 的其余 7 例未明确原因的 EAA-SCA 中,有 2 例(29%)在我们机构进行了首次 EST,导致 CPVT 诊断。
在最终诊断为 CPVT 的 15 例 SCA 幸存者中,有 1/3 的患者由于 EST 从未进行或进行但被错误解释而导致诊断延迟。在年轻人中,尤其是在运动或情绪期间发生 SCA 后,EST/CPT 必须成为标准的治疗方法。